Inhaled levodopa for
INBRIJA allows patients like Jimmy and Rachel to get back to the moment by starting to work in as soon as 10 minutes
For patients taking CD/LD
As demonstrated in the SPANSM-PD clinical trial:
For use as needed when PD symptoms start to return
99.8% of 629 patients in 2 clinical trials, after instruction, demonstrated the ability to self-administer INBRIJA while in an OFF period1
Helps patients regain motor function
Starts to work in as soon as 10 minutes postdose
Hear from Movement Disorder Specialists
In the video and podcast below, different Movement Disorder Specialists share their clinical perspectives on Parkinson's disease and why physicians should consider using a therapy like INBRIJA.
For additional Clinical Perspectives including videos and podcasts, please click here.
Role of As-needed Therapies
As-needed Therapy for the Return of Parkinson's Symptoms, Selecting Appropriate Patients
Nurse Educators Are Available to Help Your Patients
Patients starting INBRIJA will be contacted by Prescription Support Services and offered the opportunity to speak with a Nurse Educator who will reinforce how to use INBRIJA.
INBRIJA is covered by most health plans
Please see Full Important Safety Information.